Toggle navigation
Home
Search
Services
Blog
Contact
About
Inhibition of Postoperative Gynecological Adhesions
Lo, Hungnan
Gliatech, Inc., Cleveland, OH, United States
Search 3 grants from Hungnan Lo
Search grants from Gliatech, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Role of the tumor suppressor KLF6 in prostate cancer
Minority Predoctoral Fellowship Program
Electronic Data Warehouse for Epilepsy Research
Grants for Interdisciplinary Training for Rural Areas
The plant hydraulic continuum from root to leaf: avoidance of catastrophic xylem failure under dynamic conditions
Recently added grants:
Chaperone-Assisted RNA Crystallography
Intrarenal Arteries Sense N-formyl Peptides Leading to Vascular Injury in Sepsis
Genetic and Molecular Dissection of Regulatory Mechanisms Underlying Temperature and Nutritional Compensation of the Circadian Clock in Neurospora crassa
Decoding the RNA Structurome: Method Development and Function Analysis.
Reducing Disparities in Early Intervention Use: The Opening Doors to Early Intervention Study
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
9R44CA083023-02
Application #
2904843
Study Section
Special Emphasis Panel (ZRG4-NURS (01))
Program Officer
Krosnick, Steven H
Project Start
1997-09-30
Project End
2001-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Institution
Name
Gliatech, Inc.
Department
Type
DUNS #
City
Cleveland
State
OH
Country
United States
Zip Code
44122
Related projects
NIH 2000
R44 CA
Inhibition of Postoperative Gynecological Adhesions
Lo, Hungnan / Gliatech, Inc.
$146,468
NIH 1999
R44 CA
Inhibition of Postoperative Gynecological Adhesions
Lo, Hungnan / Gliatech, Inc.
Comments
Be the first to comment on this grant